In a significant move towards advancing preventive healthcare diagnostics, LordsMark Industries, under its healthcare division LordsMed, has introduced 10 precision reagents designed for critical diagnostic tests.

These precision reagents boast an impressive 99.7 percent accuracy and offer a commendable shelf-life of 24 months. Positioned to cater to the rising demand in India and eyeing global expansion, the company envisions transforming the landscape of preventive healthcare diagnostics.

The newly unveiled precision reagents cover a spectrum of critical tests, including Triglycerides, Uric Acid, Alkaline Phosphatase, Bilirubin, Calcium, Creatinine, Glucose, and various serum transaminases.

Sachidanand Upadhyay, MD & CEO of LordsMark Industries, underscored the urgent need for affordable yet high-quality reagents within India's healthcare sector, emphasizing the pivotal role of preventive measures in combating diseases.

With a commitment to revolutionize disease diagnostics, LordsMark Industries aims to address the escalating demand for affordable and accurate diagnostic kits in India.

The precision reagents, manufactured in Maharashtra, will be distributed across the nation and exported to SAARC, African, and Eastern European countries. Upcoming manufacturing facilities in Lucknow and Silvassa are poised to further enhance production capacity and quality standards, setting new benchmarks in the industry.

LordsMark Industries has strategically partnered with prestigious institutes such as IIT Bombay and BARC to develop diagnostic solutions for critical diseases like sickle cell, oral cancer, and tuberculosis.

The company's expansion of manufacturing facilities in India is geared towards producing high-quality diagnostic products. Collaborations with leading institutes highlight their commitment to developing innovative and affordable diagnostic kits for crucial diseases.

Sachidanand Upadhyay, MD & CEO of Lord’s Mark Industries Ltd, expressed, “India’s demand for affordable, quality diagnostic kits is rising due to chronic diseases and increased health awareness. Our kits, with exceptional accuracy and shelf life, aim to revolutionize disease diagnostics. We’ve filed Indian patents for global acceptance and are scaling up production to meet demand.”

In conclusion, LordsMark Industries' launch of precision reagents marks a pivotal step in enhancing preventive healthcare diagnostics, offering accurate and affordable solutions to meet the evolving needs of the healthcare landscape in India and beyond. The company's vision to revolutionize disease diagnostics aligns with its commitment to advancing accessible and high-quality healthcare solutions globally.